| Intravenous arketamine for treatment-resistant depression: open-label pilot study GC Leal, ID Bandeira, FS Correia-Melo, M Telles, RP Mello, F Vieira, ... European archives of psychiatry and clinical neuroscience 271, 577-582, 2021 | 190 | 2021 |
| Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: a randomized, double-blind, non-inferiority study FS Correia-Melo, GC Leal, F Vieira, AP Jesus-Nunes, RP Mello, ... Journal of affective disorders 264, 527-534, 2020 | 151 | 2020 |
| Comparative study of esketamine and racemic ketamine in treatment-resistant depression: protocol for a non-inferiority clinical trial FS Correia-Melo, GC Leal, MS Carvalho, AP Jesus-Nunes, CBN Ferreira, ... Medicine 97 (38), e12414, 2018 | 57 | 2018 |
| Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: a comparative, randomized and double-blind study L Araújo-de-Freitas, C Santos-Lima, E Mendonça-Filho, F Vieira, ... Psychiatry Research 303, 114058, 2021 | 23 | 2021 |
| Neurocognitive effects of ketamine and esketamine for treatment-resistant major depressive disorder: a systematic review B Souza-Marques, C Santos-Lima, L Araujo-de-Freitas, F Vieira, ... Harvard Review of Psychiatry 29 (5), 340-350, 2021 | 18 | 2021 |
| Ketamine and Esketamine augmentation for suicidal ideation: a randomized, double-blinded clinical trial F Vieira, FS Correia-Melo, C Santos-Lima, B Souza-Marques, GC Leal, ... General hospital psychiatry 68, 97-99, 2021 | 18 | 2021 |
| Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study GC Leal, B Souza-Marques, RP Mello, ID Bandeira, AT Caliman-Fontes, ... Journal of Affective Disorders 330, 7-15, 2023 | 17 | 2023 |
| Ketamine in the treatment of obsessive-compulsive disorder: a systematic review ID Bandeira, DH Lins-Silva, VB Cavenaghi, I Dorea-Bandeira, ... Harvard review of psychiatry 30 (2), 135-145, 2022 | 15 | 2022 |
| Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: secondary analysis from a randomized controlled trial RP Mello, MVF Echegaray, AP Jesus-Nunes, GC Leal, GM Magnavita, ... Journal of Psychiatric Research 138, 576-583, 2021 | 15 | 2021 |
| Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression AP Jesus‐Nunes, GC Leal, FS Correia‐Melo, F Vieira, RP Mello, ... Human Psychopharmacology: Clinical and Experimental 37 (4), e2836, 2022 | 13 | 2022 |
| Mental disorders and quality of life in patients awaiting liver transplantation LNF Guerreiro-Costa, JEO Araújo-Filho, RF Marback, AP Jesus-Nunes, ... Arquivos de Gastroenterologia 56, 339-343, 2019 | 11 | 2019 |
| Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial AT Caliman-Fontes, GC Leal, FS Correia-Melo, CS Paixao, MS Carvalho, ... Trends in Psychiatry and Psychotherapy 45, 2023 | 6 | 2023 |
| Esketamine for unipolar major depression with psychotic features: a retrospective chart review and comparison with nonpsychotic depression B Souza-Marques, M Telles, GC Leal, D Faria-Guimarães, ... Journal of Clinical Psychopharmacology 42 (4), 408-412, 2022 | 6 | 2022 |
| Quality of life, risk behaviors and depression among carriers of hepatitis C virus and human T-cell lymphotropic virus type 1: a comparative study R Henrique-Araújo, LC Quarantini, AC Caribé, FC Argolo, ... Brazilian Journal of Infectious Diseases 23, 224-230, 2019 | 5 | 2019 |
| The Portuguese version of the immunosuppressant therapy adherence scale (ITAS) among liver transplant recipient patients: translation and psychometric properties AP Jesus-Nunes, M Morais-de-Jesus, A Dantas-Duarte, TM Moreira, ... Annals of hepatology 17 (1), 104-109, 2018 | 4 | 2018 |
| Comparative study of impulsiveness and risk behaviors among infected individuals with hepatitis C virus and human T-cell lymphotropic virus type 1 R Henrique-Araújo, LC Quarantini, M Morais-de-Jesus, AP Jesus-Nunes, ... Annals of Hepatology 19 (2), 166-171, 2020 | 3 | 2020 |
| Brazilian manicure: a potential dangerous behavior AP Jesus-Nunes, TM Moreira, M Morais-de-Jesus, L Araujo-de-Freitas, ... Brazilian Journal of Infectious Diseases 20, 109-110, 2016 | 2 | 2016 |
| Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine and esketamine in treatment-resistant depression? A secondary … AT Caliman-Fontes, M Telles, LNF Guerreiro-Costa, RF Marback, ... Trends in Psychiatry and Psychotherapy, 0-0, 2023 | 1 | 2023 |
| Transtorno mental e transplante hepático: um estudo de coorte de 2 anos M MORAIS-DE-JESUS, AP JESUS-NUNES, L CODES, FC ARGOLO, ... Arquivos de Gastroenterologia 59, 494-500, 2022 | 1 | 2022 |
| Letter to the editor about" comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression" DH Lins-Silva, F Vieira, B Souza-Marques, AP Jesus-Nunes, ... Journal of affective disorders 286, 117-119, 2021 | 1 | 2021 |
